{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:08:56Z","timestamp":1782511736847,"version":"3.54.5"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"15","license":[{"start":{"date-parts":[[1983,8,1]],"date-time":"1983-08-01T00:00:00Z","timestamp":428544000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Wochenschr"],"published-print":{"date-parts":[[1983,8]]},"DOI":"10.1007\/bf01497399","type":"journal-article","created":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T14:34:05Z","timestamp":1113834845000},"page":"723-736","source":"Crossref","is-referenced-by-count":14,"title":["The biological properties of immunoglobulin G and its split products [F(ab')2 and Fab]"],"prefix":"10.1007","volume":"61","author":[{"given":"H. H.","family":"Sedlacek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Gronski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Hofstaetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. J.","family":"Kanzy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. U.","family":"Schorlemmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. R.","family":"Seiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/eji.1830080315","volume":"8","author":"AK Abbas","year":"1978","unstructured":"Abbas AK, Klaus GGB (1978) Antigen-antibody complexes suppress antibody production by mouse plasmacytoma cells in vitro. Eur J Immunol 8:217","journal-title":"Eur J Immunol"},{"key":"CR2","first-page":"111","volume":"31","author":"D Alarcon-Segovia","year":"1979","unstructured":"Alarcon-Segovia D, Ruiz-Arg\u00fcelles A (1979a) Antibody penetration into living cells. A new mechanism of immunologically mediated damage. Rev Invest Clin 31:111","journal-title":"Rev Invest Clin"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/271067a0","volume":"271","author":"D Alarcon-Segovia","year":"1978","unstructured":"Alarcon-Segovia D, Ruiz-Arg\u00fcelles A, Fishbein E (1978) Antibody to nuclear ribonucleoprotein penetrates live human mononuclear cells through Fc receptors. Nature 271:67","journal-title":"Nature"},{"key":"CR4","first-page":"364","volume":"35","author":"D Alarcon-Segovia","year":"1979","unstructured":"Alarcon-Segovia D, Ruiz-Arg\u00fcelles A, Fishbein E (1979b) Antibody penetration into living cells. I. Intranuclear immunoglobulin in peripheral blood mononuclear cells in mixed connective tissue disease and systemic lupus erythematosus. Clin Exp Immunol 35:364","journal-title":"Clin Exp Immunol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.4049\/jimmunol.122.5.1855","volume":"122","author":"D Alarcon-Segovia","year":"1979","unstructured":"Alarcon-Segovia D, Ruiz-Arg\u00fcelles A, Llorente L (1979c) Antibody penetration into living cells. II. Anti-ribonucleoprotein IgG penetrates into T?lymphocytes causing their deletion and the abrogation of suppressor function. J Immunol 122:1855","journal-title":"J Immunol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/0161-5890(81)90015-8","volume":"18","author":"JP Albar","year":"1981","unstructured":"Albar JP, Juarez C, Vivanco-Martinez F, Bragado R, Ortiz F (1981) Structural requirements of rabbit IgG F(ab')2 fragment for activation of the complement system through the alternative pathway. I. Disulfide bonds. Mol Immunol 18:925","journal-title":"Mol Immunol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3181\/00379727-108-26963","volume":"108","author":"K Amiraian","year":"1961","unstructured":"Amiraian K, Leikhim EJ (1961) Interaction of fragment III of rabbit gammaglobulin and guinea-pig complement. Proc Soc Exp Biol Med 108:454","journal-title":"Proc Soc Exp Biol Med"},{"key":"CR8","first-page":"696","volume":"26","author":"HG Arlt","year":"1940","unstructured":"Arlt HG (1940) Diphtherie-Fermoserum. M\u00fcnch Med Wochenschr 26:696","journal-title":"M\u00fcnch Med Wochenschr"},{"issue":"4\/5","key":"CR9","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0171-2985(81)80092-7","volume":"159","author":"W Ax","year":"1981","unstructured":"Ax W, Kanzy EJ, Seiler FR (1981) In vivo phagocytosis: Enhancement of bacterial clearence by native and enzymetreated immunoglobulins. Immunobiology 159 (4\/5): 349","journal-title":"Immunobiology"},{"key":"CR10","first-page":"1","volume":"17","author":"S Barandun","year":"1964","unstructured":"Barandun S (1964) Die Gammaglobulintherapie. Chemische, immunologische und klinische Grundlagen. Bibl Haematol 17:1","journal-title":"Bibl Haematol"},{"key":"CR11","first-page":"475","volume":"97","author":"HW Bauer","year":"1979","unstructured":"Bauer HW, Bertling J, Romen W (1979) In vivo Studie zur Wirksamkeit der IV Immunglobulintherapie. Fortschr Med 97:475","journal-title":"Fortschr Med"},{"key":"CR12","first-page":"1113","volume":"49","author":"E Behring von","year":"1890","unstructured":"von Behring E, Kitasato S (1890) \u00dcber das Zustandekommen der Diphtherie-Immunit\u00e4t und der Tetanus-Immunit\u00e4t bei Tieren. Dtsch Med Wochenschr 49:1113","journal-title":"Dtsch Med Wochenschr"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1084\/jem.123.1.119","volume":"123","author":"A Berken","year":"1966","unstructured":"Berken A, Benaceraf B (1966) Properties of antibodies cytophilic for macrophages. J. Exp Med 123:119","journal-title":"J. Exp Med"},{"key":"CR14","unstructured":"Beyer JH, Klee M, Kaboth U, Kehl A, K\u00f6stering H, Krieger G, Nagel GA (1980) Probleme der Ersatzl\u00f6sungen, Gammaglobulinsubstitution und Tumorenhancement bei Plasmaphercsen von Tumorpatienten. Symp. \u00fcber Plasmaaustauschbehandlung in der Immunologie und Onkologie, G\u00f6ttingen"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1084\/jem.141.6.1278","volume":"141","author":"C Bianco","year":"1975","unstructured":"Bianco C, Griffin FM, Silverstein SC (1975) Studies of the macrophage complement receptors. J Exp Med 141:1278","journal-title":"J Exp Med"},{"key":"CR16","volume-title":"Structure and function of plasma proteins, Vol. 2","author":"V Bocci","year":"1976","unstructured":"Bocci V (1976) Catabolism of Plasma Proteins. In: Allison AC (ed) Structure and function of plasma proteins, Vol. 2. Plenum Publishing Corporation, New York"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1172\/JCI108647","volume":"59","author":"VP Butler Jr","year":"1977","unstructured":"Butler VP Jr, Schmidt DH, Smith TW, Haber E, Raynor BD, Demartini P (1977) Effects of sheep-digoxin-specific antibodies and their Fab-fragments on digoxin pharmacokinetics in dogs. J Clin Invest 59:345","journal-title":"J Clin Invest"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1084\/jem.132.6.1279","volume":"132","author":"JC Bystryn","year":"1970","unstructured":"Bystryn JC, Graf MW, Uhr JW (1970) Regulation of antibody formation by serum antibody. II. Removal of specific antibody by means of exchange transfusion. J Exp Med 132:1279","journal-title":"J Exp Med"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1136\/bjo.65.6.392","volume":"65","author":"CA Carter","year":"1981","unstructured":"Carter CA, Easty DL (1981) Experimental ulcerative herpetic keratitis. III. Evaluation of hyperimmune gammaglobulin therapy. Br J Ophthalmol 65:392","journal-title":"Br J Ophthalmol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.4049\/jimmunol.102.4.1008","volume":"102","author":"JC Cerottini","year":"1969","unstructured":"Cerottini JC, McConahey PJ, Dixon FJ (1969) The immunosuppressive effect of passively administered antibody IgG fragments. J Immunol 102:1008","journal-title":"J Immunol"},{"key":"CR21","volume-title":"Die Verteilung von Immunglobulinen im Pcritonealexsudat bei diffuser Peritonitis","author":"J Dethlefsen","year":"1980","unstructured":"Dethlefsen J, St\u00fcbner G (1980) Die Verteilung von Immunglobulinen im Pcritonealexsudat bei diffuser Peritonitis. 126. Norddeutscher Chirurgen-Kongress, Hamburg"},{"key":"CR22","first-page":"832","volume":"122","author":"KH Duswald","year":"1980","unstructured":"Duswald KH, M\u00fcller K, Seifert J, Ring J (1980) Wirksamkeit von i.v.-Gammaglobulin gegen bakterielle Infektionen chirurgischer Patienten. M\u00fcnch Med Wochenschr 122:832","journal-title":"M\u00fcnch Med Wochenschr"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF01241931","volume":"351","author":"P Eckert","year":"1980","unstructured":"Eckert P, Schneider M, Naber M (1980) Beitrag zur Effektivit\u00e4t der Immunglobuline bei der experimentellen Peritonitis. Langenbecks Arch Chir 351:63","journal-title":"Langenbecks Arch Chir"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4049\/jimmunol.118.2.533","volume":"118","author":"AC Ehrnst","year":"1977","unstructured":"Ehrnst AC (1977) Complement activation by measles virus cytotoxic antibodies: Alternative pathway C activation by hemagglutination-inhibition antibodies but classical activation by hemolysin antibodies. J Immunol 118:533","journal-title":"J Immunol"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.4049\/jimmunol.121.3.1206","volume":"121","author":"AC Ehrnst","year":"1978","unstructured":"Ehrnst AC (1978) Separate pathways of C activation by measles virus cytotoxic antibodies: Subclass analysis and capacity of F(ab')2 molecules to activate C via the alternative pathway. J Immunol 121:1206","journal-title":"J Immunol"},{"key":"CR26","first-page":"718","volume":"90","author":"M Eibl","year":"1978","unstructured":"Eibl M, Friers G (1978) Hemmung der Opsonisierung von E. coli durch cnzymatisch gespaltene Gammaglobuline. Wien Klin Wochenschr 90:718","journal-title":"Wien Klin Wochenschr"},{"key":"CR27","first-page":"3001","volume":"15","author":"N Enokidani","year":"1981","unstructured":"Enokidani N, Mizukoshi M, Wada S, Sugisaki Y, Hirayama Y (1981) Distribution and permeability of pepsin-treated human immunoglobulin preparation (Globulin-V) to tissues. The Clin Report 15:3001","journal-title":"The Clin Report"},{"key":"CR28","first-page":"847","volume":"124","author":"RW Ewald","year":"1979","unstructured":"Ewald RW (1979) Prophylaxe und Therapie mit IV-applizierbarem Immunglobulin: Indikationen. Pharmazeutische Zeitung 124:847","journal-title":"Pharmazeutische Zeitung"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1084\/jem.118.5.845","volume":"118","author":"JL Fahey","year":"1963","unstructured":"Fahey JL, Robinson AC (1963) Factors controlling serum gammaglobulin concentration. J Exp Med 118:845","journal-title":"J Exp Med"},{"key":"CR30","volume-title":"Infusionstherapie und Klin","author":"A Fateh-Moghadam","year":"1982","unstructured":"Fateh-Moghadam A, Besinger U, Geursen RG (1982) Ein klinisches Modell zur Regulation der humoralen Immunantwort. Proc. Heidelberger Immunglobulin-Symposium. In: Infusionstherapie und Klin. Ern\u00e4hrung, ?Sonderband?, Karger-Verlag"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1056\/NEJM198007313030505","volume":"203","author":"DT Fearson","year":"1980","unstructured":"Fearson DT, Austen KF (1980) The alternative pathway of complement ? A system for host resistance to microbial infection. N Engl J Med 203:259","journal-title":"N Engl J Med"},{"key":"CR32","first-page":"64","volume":"6","author":"K Fehr","year":"1974","unstructured":"Fehr K, Velvart M, Watanabe H, Boeni A (1974) Digestion of autologous IgG by acid lysosomal protease (cathepsin D) and its role in immune complex formation and inflammation. Adv Clin Pharmacol 6:64","journal-title":"Adv Clin Pharmacol"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1073\/pnas.77.2.1125","volume":"77","author":"L Forni","year":"1980","unstructured":"Forni L, Coutinho A, K\u00f6hler G, Jerne NK (1980) IgM antibodies induce the production of antibodies of the same specificity. Proc Natl Acad Sci USA 77:1125?1128","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR34","first-page":"75","volume":"42","author":"JK Gadd","year":"1981","unstructured":"Gadd JK, Reid KBM (1981) Importance of the integrity of the inter-heavy-chain disulfide bond of rabbit IgG in the activation of the alternative pathway of human complement by the F(ab')2 region of rabbit IgG antibody in immune aggregates. Immunology 42:75","journal-title":"Immunology"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0019-2791(71)90424-1","volume":"8","author":"V Ghetie","year":"1971","unstructured":"Ghetie V, Mota C (1971) Catabolism of rabbit immunoglobulin G by some cathepsin-rich subcellular fractions isolated from rat liver. Immunochemistry 8:89","journal-title":"Immunochemistry"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0019-2791(70)90153-9","volume":"7","author":"V Ghetie","year":"1970","unstructured":"Ghetie V, Sulica A (1970) Uptake and breakdown of rabbit immunoglobulin G by guinea pig peritoneal polymorphonuclear leukocytes. Immunochemistry 7:175","journal-title":"Immunochemistry"},{"key":"CR37","first-page":"103","volume":"4","author":"P Gronski","year":"1983","unstructured":"Gronski P, Seiler FR (1983) Spezifische Serumtherapie gestern und heute, Teil 1\/Teil 2. Fortschr Med 4:103 u. 6:199","journal-title":"Fortschr Med"},{"key":"CR38","first-page":"283","volume":"35","author":"AO Haakenstad","year":"1976","unstructured":"Haakenstad AO, Mannik M (1976) The disappearance kinetics of soluble immune complexes prepared with reduced and alkylated antibodies in mice. Lab Invest 35:283","journal-title":"Lab Invest"},{"key":"CR39","first-page":"277","volume-title":"Autoimmunity","author":"AO Haakenstad","year":"1977","unstructured":"Haakenstad AO, Mannik M (1977) The biology of immune complexes. In: Talal N (ed) Autoimmunity. Academic Press, New York, pp 277"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1084\/jem.134.3.114","volume":"134","author":"PM Henson","year":"1971","unstructured":"Henson PM (1971) Interaction of cells with immune complexes: Adherence release of constituents and tissue injury. J Exp Med 134:114","journal-title":"J Exp Med"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1172\/JCI107296","volume":"52","author":"PM Henson","year":"1973","unstructured":"Henson PM, Spiegelberg HL (1973) Release of serotonin from human platelets induced by aggregated immunoglobulins of different classes and subclasses. J Clin Invest 52:1282","journal-title":"J Clin Invest"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1055\/s-0028-1129083","volume":"104","author":"T Hess","year":"1979","unstructured":"Hess, T, Stucki P, Scholtysik G, Riesen W (1979) Antik\u00f6rperbehandlung einer Digoxin-Intoxikation bei einem Patienten mit Niereninsuffizienz. Dtsch Med Wochenschr 104:1273","journal-title":"Dtsch Med Wochenschr"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/272064a0","volume":"272","author":"MK Hoffmann","year":"1978","unstructured":"Hoffmann MK, Kappler JW (1978) Two distinct mechanisms of immune suppression by antibody. Nature 272:64","journal-title":"Nature"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0171-2985(81)80086-1","volume":"159","author":"T Hofstaetter","year":"1981","unstructured":"Hofstaetter T, Brammsen H, Gronski P, Sedlacek HH, Seiler FR (1981) Activation of human neutrophils by immune complexes and IgG aggregates. Immunobiol 159:283","journal-title":"Immunobiol"},{"issue":"Suppl","key":"CR45","first-page":"17","volume":"28","author":"MA Horwitz","year":"1980","unstructured":"Horwitz MA (1980) The roles of the Fc and C3 receptors in the phagocytosis and killing of bacteria by human phagocytes. J Reticuloendothel Soc 28:Suppl, 17","journal-title":"J Reticuloendothel Soc"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF01965227","volume":"4","author":"LJ Ignarro","year":"1974","unstructured":"Ignarro LJ (1974) Regulation of lysosomal enzyme secretion. Role in inflammation. Agents and Actions 4:241","journal-title":"Agents and Actions"},{"key":"CR47","first-page":"483","volume":"33","author":"Y Ishibashi","year":"1980","unstructured":"Ishibashi Y, Sunagawa K, Oikawa T, Kuratsuji T, Sirai Y, Minamisato S, Yamashita N, Akita H, Hotta M, Shirozaki K (1980) The effects of pepsin-treated human normal immunoglobulin preparation against experimental infections with E. coli or Ps. aeruginosa. Jap J Pediat 33:483","journal-title":"Jap J Pediat"},{"key":"CR48","first-page":"197","volume-title":"Immunopathology. Vth Int Symp Mechanisms of inflammation induced by immune reaction","author":"H Isliker","year":"1967","unstructured":"Isliker H, Jacot-Guillarmod H, Waldesbuhl M, Fellenberg RV (1967) Complement fixation by different IgG preparations and fragments. In: Miescher PA, Grabar P (eds) Immunopathology. Vth Int Symp Mechanisms of inflammation induced by immune reaction, Grune and Stratton, New York, pp 197"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1055\/s-0038-1647783","volume":"29","author":"ED Israels","year":"1973","unstructured":"Israels ED, Nisli G, Paraskevas F, Israels LG (1973) Platelet Fc receptor as a mechanism for Ag-Ab complex-induced platelet injury. Thromb Haemostas 29:434","journal-title":"Thromb Haemostas"},{"key":"CR50","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/0019-2791(76)90190-7","volume":"13","author":"DC Jackson","year":"1976","unstructured":"Jackson DC, Grant CK (1976) Tumor cell lysis mediated by IgG or F(ab')2 antibody fragments and complement. Immunochemistry 13:721","journal-title":"Immunochemistry"},{"key":"CR51","first-page":"313","volume":"153","author":"R Johannsen","year":"1977","unstructured":"Johannsen R, Enders B, Seiler FR (1977) Hemolytic and lympholytic properties of F(ab')2 fragments of antibodies: Activation via the alternate pathway. Z Immunol Forsch 153:313","journal-title":"Z Immunol Forsch"},{"key":"CR52","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0171-2985(80)80023-4","volume":"157","author":"R Johannsen","year":"1980","unstructured":"Johannsen R, Kanzy EJ, Seiler FR (1980) Involvement of the alternative pathway of complement activation as a function of antibody concentration in hemolytic and lympholytic systems. Immunobiol 157:197","journal-title":"Immunobiol"},{"key":"CR53","first-page":"141","volume":"9","author":"R Johannsen","year":"1982","unstructured":"Johannsen R, Kanzy EJ, Ackermann O, Barth R, Bengelsdorff HJ, Hinz J, Weinmann E, Gruschkau H, Seiler FR (1982) Schutzwirkung von unmodifizierten und S-sulfonierten 7S-Antik\u00f6rpern bei vier verschiedenen, experimentellen Virusinfektionen. Beitr Infusionstherap Klin Ern\u00e4hr 9:141","journal-title":"Beitr Infusionstherap Klin Ern\u00e4hr"},{"key":"CR54","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/0090-1229(76)90094-5","volume":"6","author":"PM Johnson","year":"1976","unstructured":"Johnson PM, Page-Faulk W (1976) Rheumatoid Factor: Its Nature, Specificity and Production in Rheumatoid Arthritis. Clin Immunol Immunopathol 6:414","journal-title":"Clin Immunol Immunopathol"},{"key":"CR55","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0161-5890(81)90016-X","volume":"18","author":"C Juarez","year":"1981","unstructured":"Juarez C, Albar JP, Vivanco-Martinez F, Bragado R, Ortiz F (1981) Structural requirements of rabbit IgG F(ab')2 fragment for activation of the complement system through the alternative pathway-II. Ionic and indole groups. Molec Immunol 18:935","journal-title":"Molec Immunol"},{"key":"CR56","first-page":"1393","volume":"18","author":"K Kaneko","year":"1981","unstructured":"Kaneko K, Suehiro T, Shibata Y (1981) An in vivo study concerning distribution of human immunoglobulins to the tissues of rats. Med Consultation New Remedies 18:1393","journal-title":"Med Consultation New Remedies"},{"key":"CR57","first-page":"2985","volume":"14","author":"H Kitagawa","year":"1980","unstructured":"Kitagawa H, Okumura K (1980) Blood half life and in vivo distribution of IV-immunoglobulin preparations. The Clin Report 14:2985","journal-title":"The Clin Report"},{"key":"CR58","first-page":"1453","volume":"31","author":"N Klesel","year":"1980","unstructured":"Klesel N, Limbert M (1980) Untersuchungen zur Wirkung von einem modifizerten Immunglobulin und?-Laktam-Antibiotika in der experimentellen M\u00e4use-Septik\u00e4mie. Arzneim Forsch 31:1453","journal-title":"Arzneim Forsch"},{"key":"CR59","first-page":"715","volume":"30","author":"AJ Kulberg","year":"1976","unstructured":"Kulberg AJ, Evnin DN, Tarkanova IA (1976) Enhancement of the immune response by a catabolic product of normal rabbit IgG. Immunology 30:715","journal-title":"Immunology"},{"key":"CR60","first-page":"199","volume":"34","author":"AJ Kulberg","year":"1978","unstructured":"Kulberg AJ, Bartova LM, Evnin DN (1978) Further studies of the adjuvant properties of homologous IgG split products. Mode of action of F(ab')2 and related fragments. Immunology 34:199","journal-title":"Immunology"},{"key":"CR61","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1128\/IAI.33.3.714-724.1981","volume":"33","author":"PCJ Leijh","year":"1981","unstructured":"Leijh PCJ, van den Barselaar MT, Daha MR, van Furth R (1981) Participation of immunoglobulins and complement components in the intracellular killing of Staphylococcus aureus and Escherichia coli by human granulocytes. Infect Immun 33:714","journal-title":"Infect Immun"},{"key":"CR62","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/BF01641980","volume":"6","author":"L Lindquist","year":"1978","unstructured":"Lindquist L, Jarstrand C, Lundbergh P (1978) Granulocytic function after administration of pepsin-treated human gammaglobulin. Infection 6:248","journal-title":"Infection"},{"key":"CR63","first-page":"329","volume":"40","author":"L Lindquist","year":"1981","unstructured":"Lindquist L, Lundbergh P, Maasing R (1981) Pepsin-treated human gammaglobulin in bacterial infections. A randomized study in patients with septicemia and pneumonia. Vox Sang 40:329","journal-title":"Vox Sang"},{"key":"CR64","first-page":"249","volume":"43","author":"JM Llerena","year":"1981","unstructured":"Llerena JM, Ruiz-Arg\u00fcelles A, Alarcon-Segovia D, Llorente L, Diaz-Jouanen E (1981) Antibody penetration into living cells. V. Interference between two Fc? receptor mediated functions: Antibody penetration and antibody-dependent cellular cytotoxicity. Immunology 43:249","journal-title":"Immunology"},{"key":"CR65","unstructured":"LoSpalluto J, Fehr K, Ziff M (1971) In: Barrct AJ, Dingle JT (eds) Intracellular proteases and digestion of immunoglobulins. Chapter 12, Tissue Proteinases. North-Holland Publishing Co"},{"key":"CR66","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1084\/jem.134.3.19","volume":"134","author":"M Mannik","year":"1971","unstructured":"Mannik M, Arend WP (1971) Fate of preformed immune complexes in rabbits and rhesus monkeys. J Exp Med 134:19","journal-title":"J Exp Med"},{"key":"CR67","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1084\/jem.133.4.713","volume":"133","author":"M Mannik","year":"1971","unstructured":"Mannik M, Arend WP, Hall AP, Gilliland BC (1971) Studies on antigen-antibody complexes. I. Elimination of soluble complexes from rabbit circulation. J Exp Med 133:713","journal-title":"J Exp Med"},{"issue":"Suppl","key":"CR68","first-page":"69","volume":"6","author":"PL Masson","year":"1976","unstructured":"Masson PL (1976) Circulating Antigen-Antibody Complexes. La Ricerca 6 [Suppl]:69","journal-title":"La Ricerca"},{"key":"CR69","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/BF00338890","volume":"45","author":"H Mayersbach","year":"1957","unstructured":"Mayersbach H (1957) Studien an der Leber der Maus nach parenteraler Eiwei\u00dfzufuhr. Z Zellforsch 45:483","journal-title":"Z Zellforsch"},{"key":"CR70","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0019-2791(76)90177-4","volume":"13","author":"H Menninger","year":"1976","unstructured":"Menninger H, Fehr K, B\u00f6ni A, Otto K (1976) Digestion of human immunoglobulin G by bovine cathepsin B1. Immunochemistry 13:633","journal-title":"Immunochemistry"},{"key":"CR71","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1128\/IAI.19.2.659-666.1978","volume":"19","author":"J Menzel","year":"1978","unstructured":"Menzel J, Jungfer H, Gemsa D (1978) Contribution of Immunoglobulins M and G, Complement and Properdin to the Intracellular Killing of Escherichia coli by Polymorphonuclear Leukocytes. Infect Immun 19:659","journal-title":"Infect Immun"},{"key":"CR72","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1172\/JCI105800","volume":"47","author":"RP Messner","year":"1968","unstructured":"Messner RP, Laxdal R, Quie PG, Williams RC (1968) Anti-?-globulin factors and their interaction with specific opsonins. J Clin Invest 47:1109","journal-title":"J Clin Invest"},{"key":"CR73","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/BF00225364","volume":"156","author":"D Mitrenga","year":"1975","unstructured":"Mitrenga D, Arnold W, M\u00fcller O, van Mayersbach H (1975) The fate of Injected Human IgG in the Mouse Liver. Uptake, Immunological Inactivation and Lysosomal Reactions. Cell Tissue Res 156:359","journal-title":"Cell Tissue Res"},{"key":"CR74","first-page":"80","volume":"110","author":"A Morell","year":"1980","unstructured":"Morell A, Skvaril F (1980) Struktur und biologische Eigenschaften von Immunglobulinen und Gammaglobulin-Pr\u00e4paraten. II. Eigenschaften von Gammaglobulin-Pr\u00e4paraten. Schweiz Med Wochenschr 110:80","journal-title":"Schweiz Med Wochenschr"},{"key":"CR75","first-page":"16","volume-title":"Substitution mit Immunglobulinen bei prim\u00e4rem Antik\u00f6rpermangelsyndrom. Beitr: Infusionstherapie Klin Ern\u00e4hr","author":"A Morell","year":"1982","unstructured":"Morell A, Barandun S (1982) Substitution mit Immunglobulinen bei prim\u00e4rem Antik\u00f6rpermangelsyndrom. Beitr: Infusionstherapie Klin Ern\u00e4hr, Vol 9, pp 16?24, Karger, Basel"},{"key":"CR76","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.4049\/jimmunol.120.5.1669","volume":"120","author":"EL Morgan","year":"1978","unstructured":"Morgan EL, Tempelis CH (1978) The requirement for the Fc portion of antibody in antigen-antibody complex-mediated suppression. J Immunol 120:1669","journal-title":"J Immunol"},{"key":"CR77","first-page":"1967","volume":"30","author":"H Moriyama","year":"1979","unstructured":"Moriyama H, Manabe R (1979) Pepsin-treated gammaglobulin (Gamma-Venin). Therapy in herpetic keratouveitis. Folia Ophthalmol Jpn 30:1967","journal-title":"Folia Ophthalmol Jpn"},{"key":"CR78","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1055\/s-0038-1651256","volume":"20","author":"C M\u00fcller-Eckhardt","year":"1968","unstructured":"M\u00fcller-Eckhardt C, L\u00fcscher EF (1968) Immune reactions of human blood platelets. I. A comparative study on the effect on platelets of heterologous anti-platelet antiserum, antigenantibody complexes, aggregated gammaglobulin and thrombin. Thromb Haemostas 20:155","journal-title":"Thromb Haemostas"},{"key":"CR79","first-page":"285","volume-title":"Methods in Enzymology, Vol XIX","author":"MJ Mycek","year":"1970","unstructured":"Mycek MJ (1970) Cathepsins (Chapter 19) In: Perlman GE, Lorand L (eds) Methods in Enzymology, Vol XIX, Proteolytic Enzymes. Academic Press, New York, London, pp 285"},{"key":"CR80","first-page":"125","volume":"19","author":"JB Natvig","year":"1970","unstructured":"Natvig JB (1970) Human Anti-?-Globulin Antibodies Specific for?G Heavy Chain Subclasses. Immunology 19:125","journal-title":"Immunology"},{"key":"CR81","first-page":"554","volume":"75","author":"I Neu","year":"1980","unstructured":"Neu I (1980) Der therapeutsiche Wert von Immunglobulinen bei Infektionen des Zentralnervensystems. Med Klin 75:554","journal-title":"Med Klin"},{"key":"CR82","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1128\/IAI.33.1.109-114.1981","volume":"33","author":"JE Oakes","year":"1981","unstructured":"Oakes JE, Lausch RN (1981) Role of Fc fragments in antibodymediated recovery from ocular and subcutaneous herpes simplex virus infections. Infect Immun 33:109","journal-title":"Infect Immun"},{"key":"CR83","first-page":"151","volume":"35","author":"J Oberbarnscheidt","year":"1978","unstructured":"Oberbarnscheidt J, K\u00f6lsch E (1978) Direct blockade of antigenreactive B lymphocytes by immune complexes. An ?off? signal for precursors of IgM-producing cells provided by the linkage of antigen- and Fc-receptors. Immunology 35:151","journal-title":"Immunology"},{"key":"CR84","first-page":"64","volume":"207","author":"HR Ochs","year":"1978","unstructured":"Ochs HR, Vatner SF, Smith TW (1978) Reversal of inotropic effects of digoxin by specific antibodies and their Fab fragments in the conscious dog. J Pharmacol Exp Ther 207:64","journal-title":"J Pharmacol Exp Ther"},{"key":"CR85","first-page":"641","volume":"42","author":"A Ohtsu","year":"1979","unstructured":"Ohtsu A, Yamagami E, Watanabe T, Kurozumi S (1979) Immune reactions of platelets: Two different types of immune platelet agglutination and their comparative studies on the effects of Fc activities. Acta Haematol Jap 42:641","journal-title":"Acta Haematol Jap"},{"key":"CR86","first-page":"209","volume":"74","author":"K Okita","year":"1979","unstructured":"Okita K, Hayakawa K, Inoue Y, Nishino K, Satoh M (1979) A clinical study of the effectiveness of a pepsin-treated human normal immunoglobulin preparation (Gamma-Venin) in the treatment of Herpes Zoster. Acta Dermatol 74:209","journal-title":"Acta Dermatol"},{"key":"CR87","first-page":"267","volume":"19","author":"H Onyewotu","year":"1975","unstructured":"Onyewotu H, Johnson PM, Johnson GD, Holborow EJ (1975) Enhanced uptake by guinca pig macrophages of radio-iodinated human aggregated immunoglobulin G in the presence of sera from rheumatoid patients with cutaneous vasculitis. Clin Exp Immunol 19:267","journal-title":"Clin Exp Immunol"},{"key":"CR88","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000460705","volume":"8","author":"CK Osterland","year":"1963","unstructured":"Osterland CK, Harboe M, Kunkel HG (1963) Anti-gammaglobulin factors in human sera revealed by enzymatic splitting of anti-RM antibodies. Vox Sang 8:133","journal-title":"Vox Sang"},{"key":"CR89","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1084\/jem.143.5.1027","volume":"143","author":"LH Perrin","year":"1976","unstructured":"Perrin LH, Joseph BS, Cooper NR, Oldstone MBA (1976) Mechanism of injury of virus-infected cells by antiviral antibody and complement: Participation of IgG, F(ab')2 and the alternative complement pathway. J Exp Med 143:1027","journal-title":"J Exp Med"},{"key":"CR90","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/0161-5890(79)90099-3","volume":"16","author":"HE Prince","year":"1979","unstructured":"Prince HE, Folds JD, Spitznagel JK (1979a) In vitro production of a biologically active F(ab')2-like fragment by digestion of human IgM rheumatoid factor with human polymorphonuclear leukocyte elastasc. Mol Immunol 16:975","journal-title":"Mol Immunol"},{"key":"CR91","first-page":"162","volume":"37","author":"HE Prince","year":"1979","unstructured":"Prince HE, Folds JD, Spitznagel JK (1979b) Proteolysis of human IgG by human polymorphonuclear leukocyte elastase produces an Fc fragment with in vitro biological activity. Clin Exp Immunol 37:162","journal-title":"Clin Exp Immunol"},{"key":"CR92","first-page":"1227","volume":"121","author":"M Probst","year":"1979","unstructured":"Probst M, Fabian W (1979) Zum Einsatz von Immunglobulinen als Fr\u00fchtherapie nach Rektumexstirpation. M\u00fcnch Med Wochenschr 121:1227","journal-title":"M\u00fcnch Med Wochenschr"},{"key":"CR93","first-page":"156","volume":"18","author":"H Ronneberger","year":"1978","unstructured":"Ronneberger H, Vollerthun R, Zwisler O (1978) Intrazellul\u00e4re Verteilung von intraven\u00f6s verabreichbarem homologem Immunglobulin in der Leber. Die Gelben Hefte 18:156","journal-title":"Die Gelben Hefte"},{"key":"CR94","first-page":"17","volume":"17","author":"H Ronneberger","year":"1977","unstructured":"Ronneberger H, Zwisler O (1977) Antibakterielle Wirkung von Immunglobulinen: Schutzversuch. Die Gelben Hefte 17:17","journal-title":"Die Gelben Hefte"},{"key":"CR95","first-page":"184","volume":"86","author":"GB Ryan","year":"1977","unstructured":"Ryan GB (1977) Acute inflammation. Am J Pathol 86:184","journal-title":"Am J Pathol"},{"key":"CR96","volume-title":"Katabolismus und Verteilung von Immunglobulin SRK wie sulfoniertem Gammaglobulin im menschlichen Organismus","author":"D Ryser","year":"1979","unstructured":"Ryser D (1979) Katabolismus und Verteilung von Immunglobulin SRK wie sulfoniertem Gammaglobulin im menschlichen Organismus. Dissertation, Bern"},{"key":"CR97","unstructured":"Schmidt H (1939) Fermo-Serum: \u00dcber ein neues Reinigungsund Konzentrationsverfahren f\u00fcr Sera zur Verringerung der Serum-Krankheit. Behringwerke-Merkbl\u00e4tter, Nr 9"},{"key":"CR98","volume-title":"Immunglobuline. Prophylaxe und Therapie","author":"J Schneider","year":"1974","unstructured":"Schneider J, Weitzel H (1974) Immunglobuline. Prophylaxe und Therapie. Med Verlagsgesellschaft, Marburg"},{"key":"CR99","volume-title":"Therapie mit Immunglobulin SRK bei 12 Patienten mit prim\u00e4rem Antik\u00f6rpermangelsyndrom","author":"M Schnoz","year":"1979","unstructured":"Schnoz M (1979) Therapie mit Immunglobulin SRK bei 12 Patienten mit prim\u00e4rem Antik\u00f6rpermangelsyndrom. Dissertation, Bern"},{"key":"CR100","first-page":"781","volume":"31","author":"HU Schorlemmer","year":"1976","unstructured":"Schorlemmer HU, Allison AC (1976) Effects of activated complement components on enzyme sccretion by macrophages. Immunology 31:781","journal-title":"Immunology"},{"key":"CR101","first-page":"929","volume":"32","author":"HU Schorlemmer","year":"1977","unstructured":"Schorlemmer HU, Bitter-Suermann D, Allison AC (1977) Complement activation by the alternative pathway and macrophage enzyme secretion in the pathogencsis of chronic inflammation. Immunology 32:929","journal-title":"Immunology"},{"key":"CR102","first-page":"207","volume":"22","author":"HU Schorlemmer","year":"1980","unstructured":"Schorlemmer HU, Scdlacek HH, Seiler FR, Bitter-Suermann D, (1980) Evidence of rht participation of endogenous C3 in macrophage stimulation. Eur J Cell Biol 22:207","journal-title":"Eur J Cell Biol"},{"key":"CR103","first-page":"108","volume":"159","author":"HU Schorlemmer","year":"1981","unstructured":"Schorlemmer HU, Gronski P, Hofstaetter T, Sedlacck HH, Seiler FR (1981) Aggregates of human IgG and immune complexes containing 7S-IgG or 5S-F(ab?)2 antibodies activate macrophages by different mechanisms. Immunobiology 159:108","journal-title":"Immunobiology"},{"key":"CR104","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1055\/s-0028-1113997","volume":"34","author":"HE Schultze","year":"1962","unstructured":"Schultze HE, Schwick G (1962) \u00dcber neue M\u00f6glichkeiten intraven\u00f6ser Gammaglobulin-Applikation. Dtsch Med Wochenschr 34:1643","journal-title":"Dtsch Med Wochenschr"},{"key":"CR105","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1084\/jem.118.6.891","volume":"118","author":"PJ Schur","year":"1963","unstructured":"Schur PJ, Becker EL (1963) Pepsin digestion of rabbit and sheep antibodies. The effect on complement fixation. J Exp Med 118:891","journal-title":"J Exp Med"},{"key":"CR106","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/BF01477164","volume":"58","author":"HH Sedlacek","year":"1980","unstructured":"Sedlacek HH (1980a) Pathophysiological aspects of immune complex diseases. Part I. Interaction with plasma enzyme systems, cell membranes and the immune response. Klin Wochenschr 58:543","journal-title":"Klin Wochenschr"},{"key":"CR107","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/BF01477835","volume":"58","author":"HH Sedlacek","year":"1980","unstructured":"Sedlacek HH (1980b) Pathophysiological aspects of immune complex diseases. Part II. Phagocytosis, exocytosis and pathogenic Depositions. Klin Wochenschr 58:593","journal-title":"Klin Wochenschr"},{"key":"CR108","first-page":"78","volume":"64","author":"HH Sedlacek","year":"1979","unstructured":"Sedlacek HH, Bengelsdorff HJ, Seiler FR (1979a) Concepts for the therapy of immune complex diseases. Behring Inst Mitt 64:78","journal-title":"Behring Inst Mitt"},{"key":"CR109","first-page":"131","volume":"64","author":"HH Sedlacek","year":"1979","unstructured":"Sedlacek HH, L\u00fcben G, Bengelsdorff HJ, Gronski P, Schmidt KH, Seiler FR (1979b) Different biological distribution of immune complexes of varying antigen-antibody composition and lattice formation. Behring Inst Mitt 64:131","journal-title":"Behring Inst Mitt"},{"key":"CR110","first-page":"207","volume-title":"Immunoglobulins: Characteristics and Uses of Intravenous Preparations. DHEW Publication No. (FDA)-80-9005","author":"FR Seiler","year":"1980","unstructured":"Seiler FR, Kanzy EJ, Ax W, Hofstactter T (1980) Quality criteria for intravenous immunoglobulin preparations with emphasis on Fe-mediated functions and phagocytosis. In: Alving BM, Finlayson JS (eds) Immunoglobulins: Characteristics and Uses of Intravenous Preparations. DHEW Publication No. (FDA)-80-9005, Washington DC, US Government Printing Office, pp 207"},{"key":"CR111","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/eji.1830090509","volume":"9","author":"ZB Shavit","year":"1979","unstructured":"Shavit ZB, Raz A, Goldman R (1979) Complement and Fereceptor-mediated phagocytosis of normal and stimulated mouse peritoneal macrophages. Eur J Immunol 9:385","journal-title":"Eur J Immunol"},{"key":"CR112","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.4049\/jimmunol.123.5.2144","volume":"123","author":"JGP Sissons","year":"1979","unstructured":"Sissons JGP, Cooper NR, Oldstone MBA (1979) Alternative complement pathway-mediated lysis of measles virus infected cells: Induction by IgG antibody bound to individual viral glycoproteins and comparative efficacy of F (ab?)2 and Fab fragments. J Immunol 123:2144","journal-title":"J Immunol"},{"key":"CR113","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1084\/jem.148.4.903","volume":"148","author":"JL Snick van","year":"1978","unstructured":"van Snick JL, Masson PL (1978) The effect of complement on the ingestion of soluble antigen-antibody complexes and IgM aggregates by mouse peritoneal macrophages. J Exp Med 148:903","journal-title":"J Exp Med"},{"key":"CR114","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/eji.1830080412","volume":"8","author":"JL Snick van","year":"1978","unstructured":"van Snick JL, van Roost E, Markowetz B, Cambiaso CL, Masson PL (1978) Enhancement by IgM rheumatoid factor of in vitro ingestion by macrophages and in vivo clearance of aggregated IgG or antigen antibody complexes. Eur J Immunol 8:279","journal-title":"Eur J Immunol"},{"key":"CR115","first-page":"655","volume":"31","author":"HL Spiegelberg","year":"1972","unstructured":"Spiegelberg HL, G\u00f6tze O (1972) Conversion of C3 proactivator and activation of the alternate pathway of complement activation by different classes and subclasses of human immunoglobulins. Fed Proc 31:655","journal-title":"Fed Proc"},{"key":"CR116","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0019-2791(77)90141-0","volume":"14","author":"EJ Steele","year":"1977","unstructured":"Steele EJ, Reynolds BL, Rother U, Rowley D (1977) The mechanism of complement fixation by rabbit F (ab?)2: Bacteriacidal activity of chelated serum and C4-deficient serum. Immunochemistry 14:681","journal-title":"Immunochemistry"},{"key":"CR117","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0019-2791(77)90230-0","volume":"14","author":"EJ Steele","year":"1977","unstructured":"Steele EJ, Rowley D (1977) The mechanisms of complement fixation by rabbit F(ab?)2: Properties of the bactericidal reaction. Immunochemistry 14:319","journal-title":"Immunochemistry"},{"key":"CR118","first-page":"11","volume":"32","author":"O Stendahl","year":"1977","unstructured":"Stendahl O, Tagesson C, Magnusson KE, Edebo L (1977) Physicochemical consequences of opsonization of Salmonella typhimurium with hyperimmune IgG and complement. Immunology 32:11","journal-title":"Immunology"},{"key":"CR119","first-page":"116","volume":"30","author":"W Stephan","year":"1980","unstructured":"Stephan W (1980) Intraven\u00f6se Immunglobuline. Proteinchemische und immunbiologische Charakterisierung der verschiedenen Pr\u00e4paratetypen. Arzneim Forsch 30:116","journal-title":"Arzneim Forsch"},{"key":"CR120","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1056\/NEJM197110212851709","volume":"285","author":"J Stokes","year":"1951","unstructured":"Stokes J (1951) Usefulness of immune serum globulin in viral hepatitis. N Engl J Med 285:967","journal-title":"N Engl J Med"},{"key":"CR121","first-page":"134","volume":"27","author":"M Takahashi","year":"1980","unstructured":"Takahashi M, Takahashi S, Hirose S (1980) Solubilization of Antigen-Antibody Complexes: A New Function of Complement as a Regulator of Immune Reactions. Prog Allergy 27:134","journal-title":"Prog Allergy"},{"key":"CR122","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/infdis\/99.1.21","volume":"99","author":"WH Taliaferro","year":"1956","unstructured":"Taliaferro WH, Talmage DW (1956) Antibodies in the rabbit with different rates of metabolic decay. J Infect Dis 99:21","journal-title":"J Infect Dis"},{"key":"CR123","first-page":"531","volume":"100","author":"AN Theofilopoulos","year":"1980","unstructured":"Theofilopoulos AN, Dixon FJ (1980) Immune Complexes in Human Diseases. A review. Am J Pathol 100:531","journal-title":"Am J Pathol"},{"key":"CR124","first-page":"155","volume-title":"Schutzwirkung verschiedener Antik\u00f6rperpr\u00e4parationen bei einer experimentellen bakteriellen Scpsis. Beitr: Infusionstherapie Klin Ern\u00e4hr, Vol 9","author":"M Trautmann","year":"1982","unstructured":"Trautmann M, Br\u00fcckner O, Hofstaetter T, Seiler FR, Hahn H (1982) Schutzwirkung verschiedener Antik\u00f6rperpr\u00e4parationen bei einer experimentellen bakteriellen Scpsis. Beitr: Infusionstherapie Klin Ern\u00e4hr, Vol 9, pp 155?165. Karger, Basel"},{"key":"CR125","first-page":"251","volume":"120","author":"KD Tympner","year":"1976","unstructured":"Tympner KD, Klose PK, Janka G, Liegel D (1976) Einflu\u00df intraven\u00f6s-vertr\u00e4glicher Immunglobuline auf die Phagozytose-Leistung der Granulozyten in vitro. M\u00fcnch Med Wochenschr 120:251","journal-title":"M\u00fcnch Med Wochenschr"},{"key":"CR126","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1084\/jem.113.5.935","volume":"113","author":"JW Uhr","year":"1961","unstructured":"Uhr JW, Baumann JB (1961) Antibody Formation. I. The Suppression of Antibody Formation by Passively Administered Antibody. J Exp Med 113:935","journal-title":"J Exp Med"},{"key":"CR127","first-page":"22","volume":"93","author":"B Urbaschek","year":"1975","unstructured":"Urbaschek B (1975) Zur pathophysiologischen Bedeutung der Endotoxine. Fortschr Med 93:22","journal-title":"Fortschr Med"},{"key":"CR128","first-page":"26","volume":"235","author":"B Urbaschek","year":"1976","unstructured":"Urbaschek B (1976) Zur Frage der pathogenetischen Bedeutung von Endotoxinen bei Infektionen mit gramnegativen Bakterien. Zentralbl Bakteriol Mikrobiol Hyg [B] 235:26","journal-title":"Zentralbl Bakteriol Mikrobiol Hyg [B]"},{"key":"CR129","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/BF00237886","volume":"213","author":"R Vollerthun","year":"1980","unstructured":"Vollerthun R, M\u00f6ller W (1980) Uptake and Transport of Immunoglobulin in the Chick Coroid Plexus. I. Studies with Enzyme-treated Human Immunoglobulin in Tissue Culture. Cell Tissue Res 213:393","journal-title":"Cell Tissue Res"},{"key":"CR130","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1055\/s-0028-1104953","volume":"102","author":"R Vollerthun","year":"1977","unstructured":"Vollerthun R, Sedlacek HH, Ronneberger H (1977) Gewebeverteilung von nativem und enzymbehandeltem Human-Immunglobulin. Experimentelle Untersuchungen. Dtsch Med Wochenschr 102:684","journal-title":"Dtsch Med Wochenschr"},{"key":"CR131","first-page":"1","volume":"13","author":"TA Waldmann","year":"1969","unstructured":"Waldmann TA, Strober W (1969) Metabolism of immunoglobulin. Prog Allergy 13:1","journal-title":"Prog Allergy"},{"key":"CR132","doi-asserted-by":"crossref","first-page":"399","DOI":"10.4049\/jimmunol.35.5.399","volume":"35","author":"AJ Weil","year":"1938","unstructured":"Weil AJ, Parfentjev JV, Bowmann KL (1938) Antigenic Qualities of Antitoxins. J Immunol 35:399","journal-title":"J Immunol"},{"key":"CR133","first-page":"121","volume":"64","author":"E Wei\u00dfbarth","year":"1979","unstructured":"Wei\u00dfbarth E, Sedlacek HH, Seiler FR, Fricke M, Deicher H (1979) Release of3H-serotonin and endogenous ?-thromboglobulin from human platelets by immune complexes. Behring Inst Mitt 64:121","journal-title":"Behring Inst Mitt"},{"key":"CR134","first-page":"11","volume":"2","author":"O Zwisler","year":"1978","unstructured":"Zwisler O, Joachim I (1978) Ampicillin-resistente Mutanten von Staph. aureus durch Gammaglobulin reduziert. Diagnostik Intensivther 2:11","journal-title":"Diagnostik Intensivther"},{"key":"CR135","first-page":"1509","volume":"84","author":"O Zwisler","year":"1978","unstructured":"Zwisler O, Ronneberger H (1978) Steigerung der Wirkung von Ampicillin durch intraven\u00f6s applizierbares 5S-Immunglobulin. Verh Dtsch Ges Inn Med 84:1509","journal-title":"Verh Dtsch Ges Inn Med"}],"container-title":["Klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01497399.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01497399\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01497399","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T23:19:15Z","timestamp":1706138355000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01497399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983,8]]},"references-count":135,"journal-issue":{"issue":"15","published-print":{"date-parts":[[1983,8]]}},"alternative-id":["BF01497399"],"URL":"https:\/\/doi.org\/10.1007\/bf01497399","relation":{},"ISSN":["0023-2173","1432-1440"],"issn-type":[{"value":"0023-2173","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[1983,8]]}}}